International relations
Global pandemic treaty to be concluded by 2025, WHO says
Talks extended amid divisions between rich and poorer countries
Medicines and equipment hit by weak demand amid slow global recovery
Chief Medical Officer Paul Burton highlights room for region-specific shots
Once-a-year boosters would be given ahead of year-end holidays
Drugmaker targets capacity of 20m doses yearly, boosting nation's preparedness
Overloaded hospitals and morgues suggest true death toll is hidden and worst is to come
Shionogi and KM Biologics also eye homegrown shots targeting variants
Sudden policy changes, spread of virus cast shadow over 'V-shaped recovery'
Mainlanders flock to enclave, prepare for Hong Kong border to reopen to get shots
Medics needed; drugstores told to limit ibuprofen sales to 6 pills per person per week
Company aims for 73m doses by fiscal 2027 to become dominant producer
Logistics equipment to help boost vaccine shipments to islands
Government's pandemic preparation plan depends on commitments from drugmakers
Jakarta now has homegrown halal alternative to Western, Chinese shots
No-needle products win approval in India and beyond
CanSino, Sinopharm seek Chinese equivalents of Pfizer and Moderna shots
Southeast Asian country aims to be more self-sufficient in dealing with pandemic
As 20th Party Congress approaches, China appears trapped by draconian anti-virus policies
Injections due to start this month with 43m doses to be supplied nationwide
Materials maker to invest in Yokohama plant, preparing for pandemics
Country also adopts homegrown jab as it looks to build local production
Pharmaceutical first needs government to agree to long-term purchases of shots
Rollout to start as early as September with vulnerable groups
Nasdaq-listed Azenta to acquire entire stake in vaccine storage provider B Med
Homegrown vaccine developers inch closer to rollouts in Japan
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.